Literature DB >> 18292192

Tumor necrosis factor (TNF)-alpha persistently activates nuclear factor-kappaB signaling through the type 2 TNF receptor in chromaffin cells: implications for long-term regulation of neuropeptide gene expression in inflammation.

Djida Ait-Ali1, Valérie Turquier, Yannick Tanguy, Erwan Thouënnon, Hafida Ghzili, Lourdes Mounien, Céline Derambure, Sylvie Jégou, Jean-Philippe Salier, Hubert Vaudry, Lee E Eiden, Youssef Anouar.   

Abstract

Chromaffin cells of the adrenal medulla elaborate and secrete catecholamines and neuropeptides for hormonal and paracrine signaling in stress and during inflammation. We have recently documented the action of the cytokine TNF-alpha on neuropeptide secretion and biosynthesis in isolated bovine chromaffin cells. Here, we demonstrate that the type 2 TNF-alpha receptor (TNF-R2) mediates TNF-alpha signaling in chromaffin cells via activation of nuclear factor (NF)-kappaB. Microarray and suppression subtractive hybridization have been used to identify TNF-alpha target genes in addition to those encoding the neuropeptides galanin, vasoactive intestinal polypeptide, and secretogranin II in chromaffin cells. TNF-alpha, acting through the TNF-R2, causes an early up-regulation of NF-kappaB, long-lasting induction of the NF-kappaB target gene inhibitor kappaB (IkappaB), and persistent stimulation of other NF-kappaB-associated genes including mitogen-inducible gene-6 (MIG-6), which acts as an IkappaB signaling antagonist, and butyrate-induced transcript 1. Consistent with long-term activation of the NF-kappaB signaling pathway, delayed induction of neuropeptide gene transcription by TNF-alpha in chromaffin cells is blocked by an antagonist of NF-kappaB signaling. TNF-alpha-dependent signaling in neuroendocrine cells thus leads to a unique, persistent mode of NF-kappaB activation that features long-lasting transcription of both IkappaB and MIG-6, which may play a role in the long-lasting effects of TNF-alpha in regulating neuropeptide output from the adrenal, a potentially important feedback station for modulating long-term cytokine effects in inflammation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18292192      PMCID: PMC2408812          DOI: 10.1210/en.2007-1192

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  59 in total

1.  Characterization of the 5'-flanking region of the human preprogalanin gene.

Authors:  B Kofler; H F Evans; M L Liu; V Falls; T P Iismaa; J Shine; H Herzog
Journal:  DNA Cell Biol       Date:  1995-04       Impact factor: 3.311

2.  Nicotine and prostaglandin E induce secretogranin II levels in bovine chromaffin cells.

Authors:  M Wolkersdorfer; C Egger; A Laslop; R Fischer-Colbrie
Journal:  Brain Res Mol Brain Res       Date:  1996-06

3.  Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries.

Authors:  L Diatchenko; Y F Lau; A P Campbell; A Chenchik; F Moqadam; B Huang; S Lukyanov; K Lukyanov; N Gurskaya; E D Sverdlov; P D Siebert
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

4.  Epidermal growth factor activation of NF-kappaB is mediated through IkappaBalpha degradation and intracellular free calcium.

Authors:  L Sun; G Carpenter
Journal:  Oncogene       Date:  1998-04-23       Impact factor: 9.867

5.  Activation of NF-kappa B by ER stress requires both Ca2+ and reactive oxygen intermediates as messengers.

Authors:  H L Pahl; P A Baeuerle
Journal:  FEBS Lett       Date:  1996-08-26       Impact factor: 4.124

6.  Cellular communication in the neuro-adrenocortical axis: role of vasoactive intestinal polypeptide (VIP).

Authors:  S R Bornstein; A Haidan; M Ehrhart-Bornstein
Journal:  Endocr Res       Date:  1996-11       Impact factor: 1.720

7.  Interleukin-1beta and glutamate activate the NF-kappaB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures.

Authors:  M Grilli; F Goffi; M Memo; P Spano
Journal:  J Biol Chem       Date:  1996-06-21       Impact factor: 5.157

8.  A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism.

Authors:  J T Cooper; D M Stroka; C Brostjan; A Palmetshofer; F H Bach; C Ferran
Journal:  J Biol Chem       Date:  1996-07-26       Impact factor: 5.157

9.  Co-localization of calcium-modulating cyclophilin ligand with intracellular calcium pools.

Authors:  M P Holloway; R J Bram
Journal:  J Biol Chem       Date:  1998-06-26       Impact factor: 5.157

10.  Synaptic activation of NF-kappa B by glutamate in cerebellar granule neurons in vitro.

Authors:  L Guerrini; F Blasi; S Denis-Donini
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

View more
  17 in total

Review 1.  Cytokine interactions with adrenal medullary chromaffin cells.

Authors:  Shirley A Douglas; Dharshini Sreenivasan; Fiona H Carman; Stephen J Bunn
Journal:  Cell Mol Neurobiol       Date:  2010-11-19       Impact factor: 5.046

2.  Interleukin-6-mediated signaling in adrenal medullary chromaffin cells.

Authors:  Danielle E Jenkins; Dharshini Sreenivasan; Fiona Carman; Babru Samal; Lee E Eiden; Stephen J Bunn
Journal:  J Neurochem       Date:  2016-12-05       Impact factor: 5.372

Review 3.  Tyrosine-hydroxylase immunoreactivity in the mouse transparent brain and adrenal glands.

Authors:  David Godefroy; William Rostène; Youssef Anouar; Annabelle Reaux-Le Goazigo
Journal:  J Neural Transm (Vienna)       Date:  2018-09-11       Impact factor: 3.575

Review 4.  Immune-neuroendocrine integration at the adrenal gland: cytokine control of the adrenomedullary transcriptome.

Authors:  Stephen J Bunn; Djida Ait-Ali; Lee E Eiden
Journal:  J Mol Neurosci       Date:  2012-03-16       Impact factor: 3.444

5.  Involvement of epidermal growth factor receptor-linked signaling responses in Pseudomonas fluorescens-infected alveolar epithelial cells.

Authors:  Hye Jin Choi; Chan Hee Seo; Seong Hwan Park; Hyun Yang; Kee Hun Do; Juil Kim; Hyung-Kab Kim; Duk-Hwa Chung; Jung Hoon Ahn; Yuseok Moon
Journal:  Infect Immun       Date:  2011-02-22       Impact factor: 3.441

6.  Exercise-induced α-ketoglutaric acid stimulates muscle hypertrophy and fat loss through OXGR1-dependent adrenal activation.

Authors:  Yexian Yuan; Pingwen Xu; Qingyan Jiang; Gang Shu; Xingcai Cai; Tao Wang; Wentong Peng; Jiajie Sun; Canjun Zhu; Cha Zhang; Dong Yue; Zhihui He; Jinping Yang; Yuxian Zeng; Man Du; Fenglin Zhang; Lucas Ibrahimi; Sarah Schaul; Yuwei Jiang; Jiqiu Wang; Jia Sun; Qiaoping Wang; Liming Liu; Songbo Wang; Lina Wang; Xiaotong Zhu; Ping Gao; Qianyun Xi; Cong Yin; Fan Li; Guli Xu; Yongliang Zhang
Journal:  EMBO J       Date:  2020-02-27       Impact factor: 11.598

7.  Tumor necrosis factor receptor 2 (TNFR2)·interleukin-17 receptor D (IL-17RD) heteromerization reveals a novel mechanism for NF-κB activation.

Authors:  Shigao Yang; Yinyin Wang; Kunrong Mei; Sen Zhang; Xiaojun Sun; Fangli Ren; Sihan Liu; Zi Yang; Xinquan Wang; Zhihai Qin; Zhijie Chang
Journal:  J Biol Chem       Date:  2014-11-05       Impact factor: 5.157

8.  MEK, p38, and PI-3K mediate cross talk between EGFR and TNFR in enhancing hepatocyte growth factor production from human mesenchymal stem cells.

Authors:  Yue Wang; Brent R Weil; Jeremy L Herrmann; Aaron M Abarbanell; Jiangning Tan; Troy A Markel; Megan L Kelly; Daniel R Meldrum
Journal:  Am J Physiol Cell Physiol       Date:  2009-08-19       Impact factor: 4.249

9.  Discrete signal transduction pathway utilization by a neuropeptide (PACAP) and a cytokine (TNF-alpha) first messenger in chromaffin cells, inferred from coupled transcriptome-promoter analysis of regulated gene cohorts.

Authors:  Babru Samal; Djida Ait-Ali; Stephen Bunn; Tomris Mustafa; Lee E Eiden
Journal:  Peptides       Date:  2013-04-19       Impact factor: 3.750

10.  PACAP-cytokine interactions govern adrenal neuropeptide biosynthesis after systemic administration of LPS.

Authors:  Djida Ait-Ali; Nikolas Stroth; Jyoti M Sen; Lee E Eiden
Journal:  Neuropharmacology       Date:  2009-07-31       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.